In the ever-changing field of precision medicine, continuous evaluation of data sharing and collaboration practices is essential for biotech and pharma companie...
Continue reading
Drug development remains one of the most complex, costly, and failure-prone processes in the life sciences. Traditional approaches rely heavily on trial-and-err...
Continue reading
As the new year unfolds, it's a time for reflection on some of the most inspirational stories in human genetics last year, and anticipation of what's to come in...
Continue reading
Genetic variation across populations has direct consequences for precision medicine trial design. As patient populations in clinical research become more ethnic...
Continue reading
Our new whitepaper "Inclusive genomics: A path to equitable precision medicine" offers a close look at the intersection of genomic research and diversity. It's ...
Continue reading
The 34th International Symposium on ALS/MND arrived at a moment of real momentum in ALS research. The field has seen a significant expansion in genetic understa...
Continue reading
In the ever-evolving landscape of healthcare, precision medicine trials stand out as a beacon of personalised treatment, tailored to the unique genetic and envi...
Continue reading
As precision medicine advances from concept to clinical practice, its economic implications are becoming a central question for sponsors, health systems, and po...
Continue reading
This webinar, hosted by Sano CEO Dr. Patrick Short and featuring David Ochoa, Platform Coordinator at Open Targets, explores the significance of human genetics ...
Continue reading
As precision medicine trials increasingly depend on genetic eligibility criteria, the process of testing, interpreting results, and guiding patients through the...
Continue reading